. Author manuscript; available in PMC: 2013 Mar 27.

Published in final edited form as: Vasc Med. 2012 Mar 8;17(2):94–100. doi: 10.1177/1358863X11436334

Table 2.

Differences at baseline in skeletal muscle VEGF concentration, number of capillaries/fiber and capillaries/mm², and peak VO₂ among control and PAD subjects

	VEGF-A	VEGF_l65b	VEGF-R1	Capillary supply	Capillary supply	Peak VO₂

	pg VEGF-A/mg protein	pg VEGF_l65b/mg protein	pg VEGF-R1/mg protein	Capillaries/mm²	Capillaries/fiber	ml/kg/min
Control	116.5 ± 56.6	2120.6 ± 819.1	508.6 ± 313.8^*	317.6 ± 87.2^*	2.2 ± 0.7^*	25.6 ± 6.6^*
	n = 30	n = 14	n = 28	n = 26	n = 26	n = 29
PAD	119.3 ± 73.9	1720.1 ± 743.5	177.3 ± 133.3	247.7 ± 69.8	1.8 ± 0.6	16.9 ± 4.2
	n = 22	n = 17	n = 20	n = 22	n = 22	n = 22

p < 0.05 between control and PAD patients.

PAD, peripheral artery disease; peak VO₂, peak oxygen consumption; pg, picogram; VEGF, vascular endothelial growth factor; VEGF-R1, vascular endothelial growth factor receptor 1.